167
Views
19
CrossRef citations to date
0
Altmetric
Endometriosis

Peritoneal fluid proteome in women with different ASRM stages of endometriosis

, , , , &
Pages 433-441 | Received 28 Jan 2008, Accepted 29 Apr 2008, Published online: 07 Jul 2009
 

Abstract

Objective. Endometriosis has a wide range of severity but molecular factors associated with variable extension of the disease have not been widely investigated. The present study compares the peritoneal fluid (PF) proteome of 109 women with endometriosis and different disease stage as defined by the American Society for Reproductive Medicine (ASRM).

Methods. PF samples were subjected to two-dimensional gel electrophoresis; protein spots of interest were identified by liquid chromatography tandem mass spectrometry.

Results. Over 470 protein spots were analyzed. One isoform of haptoglobin α chain, α-1b-glycoprotein and one unknown protein had higher expression in PF of women with ASRM stage I–II endometriosis. Four isoforms of α1-antitrypsin, three isoforms of α-1b-glycoprotein, one isoform of S100-A8 and serotransferrin had higher expression in PF of women with ASRM stage III–IV disease.

Conclusions. Several protein isoforms have different expression in PF of women with ASRM stage I–II endometriosis than in those with ASRM stage III–IV disease; most of these molecules are involved in inflammation and immune response.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.